陳信義(北京東直門血液科專家)

本詞條是多義詞,共2個義項
更多義項 ▼ 收起列表 ▲

陳信義,男,是北京東直門血液科專家。

基本介紹

  • 中文名稱:陳信義
  • 國籍:中國
  • 出生日期:1954年
  • 職業:醫生
  • 臨床職稱:主任醫師
  • 專業:中醫系
  • 教學職稱:教授,博士生導師
出診時間,個人經歷,社會任職,

出診時間

周二上午專家門診;地點:門診1診室
周四上午特需門診;地點:特需4診室
周二下午特需門診;地點:特需4診室
預約掛號,預約手術和預約住院可以諮詢中華名醫匯網,提供廣州和北京三甲醫院的醫生,手術和住院預約服務。
專業特長
難治性白血病、難治性血小板減少症、各種實體腫瘤、腫瘤多藥耐藥。

個人經歷

1954年生,博士生導師,博士後合作導師。國家級重點學科“中醫內科學”學術帶頭人,國家中醫藥管理局重點學科“中醫內科血液病學科”帶頭人。全國衛生戰線精神文明先進工作者,中國百名傑出青年中醫師,北京市優秀青年骨幹教師,北京市愛國立功標兵。
從事中醫及中西醫結合臨床醫療20餘年。以中醫內科及中西醫結合血液、腫瘤性疾病為專業特長。特別對骨髓增生異常綜合徵再生障礙性貧血、難治性血小板減少性紫癜、缺鐵性貧血急性白血病肺癌、肝癌等辨證施治有獨特見解,且臨床療效顯著。近年來,主要從事中醫藥治療難治性白血病、中醫藥治療難治性血小板減少性紫癜、中醫藥預防/逆轉腫瘤多藥耐藥研究。共培養碩士30餘名,博士15餘名,博士後2名。並有多名博士生曾在清華大學軍事醫學科學院美國維吉尼亞大學等國內外知名高校或研究機構的博士後流動站工作。
作為大學科研骨幹,曾先後主持部國家九五重大科技攻關計畫課題1項,主持並參加國家十?五重大科技攻關課題各1項,國家自然科學基金委員會課題3項,衛生部科研基金課題3項,教育部高等學校博士點專項基金4項,國家中醫藥管理局科研基金2項,首都醫學發展基金重大聯合項目2項、北京中醫藥大學科研基金6項。指導下級醫師開展科研課題研究8項。獲得科研成果與獎勵6項,申請專利4項,開發中藥新藥2項,發表臨床與科學研究論文100餘篇,主編《內科診療常規》、《骨髓增生異常綜合徵症治》、《中西醫結合血液病手冊》、《中醫臨床血液病學》、《常見血液病中醫診療範例》等專業著作;參加《中醫腫瘤學》編著,主審《中醫血液病學》;目前,擔任國家中醫藥管理局21世紀高等中醫藥院校全國規劃教材《中西醫結合腫瘤學》、北京市高等學校精品教材《中西醫結合內科學》副主編。
XinYi Chen,M.D., Chief physician,Professor, Director, Department of internal medicine and department of Oncology and Hematology of Dongzhimen Hospital affiliated to Beijing Uiversity of TCM
Biographical Sketch
Dr. Chen is a board certified medical oncologist and a cancer researcher . Dr Chen graduated from
Beijing University of Traditional Chinese Medicine with M.B.A in 1978 , and he has completed the course from the resident to the head of Internal Medicine since 1978 at Dongzhimen Hospital, affiliated with the Beijing University of Traditional Chinese Medicine.
Dr. Chen has been engaged in Chinese medicine and integrated TCM with Western medicine clinical care for 28 years. He has majored in internal medicine of TCM and hematological and oncological diseases. In many diseases like abnormal myelodysplastic syndrome, aplastic anemia, refractory purpura haemorrhagica, hypoferric anemia, acute leukemia, lung cancer, hepatoma, he has his own peculiar opinions and has got significant curative effect. In recent years, he has mainly dealed with clinical study of prophylaxis or reverse multidrug resistance of leukemia with Chinese medicine. Up until now, he has cultivated over 30 masters, 15 doctors and 2 post doctors, and several of them had been working in post-doctoral circulating station famous university or research institute like Tsinghua University, academy of military medical sciences, Virginia University of America. As one of the backbones of our university, he has presided over one important topic of tackling key problems in science and technology of the ninth 5-year-program, presided over and participated in one important topic of tackling key problems in science and technology of the tenth 5-year-program, 3 topics of national natural science fund committee, 3 topics of scientific research fund of Ministry of Health, 4 topics of special-purpose for doctorship-awarded units of university of ministry of education, 2 topics of scientific research fund of State Administration of TCM, 2 important cooperate projects of capital medical developing fund and 6 projects of scientific research fund of Beijing university of TCM.
Dr. Chen was served as one of new drug judging experts of state food and drug administration bureau, one of judging experts of middle and small business creation fund of ministry of technology, one of new drug judging commission of ministry of technology, judging commission of state key new products counseling experts of state basic medical insurance expert of malpractice evaluation committee of the Chinese medical association(CMA), and one of judging experts of plan of state key new drugs member of Beijing laboring evaluation committee member of malpractice evaluation committee of Dongcheng District, Beijing . And he was chosen as the expert of evaluation committee of Beijing science and technology reward member of Beijing advisory council of adverse effect of drugs expert of peer evaluation of state natural science fund committee , the expert of evaluation committee of Chinese medical technology prize and Chinese medical youth prize, the judging expert of technology reward of state administration of TCM, and the judging expert of technology reward of society of TCM member of academic degree .He was also served as the associate director of committee of oncology of Chinese TCM association, the associate director of committee of hematology of internal medicine of TCM of Chinese TCM association, the associate director of committee of oncology of internal medicine of TCM of Beijing anticancer association, and the associate director of committee of oncology of internal medicine of TCM of Beijing TCM association. He was also chosen as the deputy of internal medicine of Beijing TCM association ,the deputy of oncology committee of Chinese society of combination of TCM with Western medicine, the deputy of hematology committee of Chinese society of combination of TCM with Western medicine, the deputy of oncology committee of TCM, Chinese anticancer society, and the deputy of fund committee of Chinese anticancer society.

社會任職

中華中醫藥學會腫瘤專業委員會副主任委員
中國中西醫結合學會血液病專業委員會副主任委員
中華中醫藥學會中醫內科血液病學術委員會副主任委員
北京市中醫藥學會中醫腫瘤專業委員會副主任委員
北京市抗癌協會中醫腫瘤專業委員會副主任委員
國家食品藥品監督管理局新藥審評專家
中華人民共和國科技部中小型企業創新基金評審專家
中華人民共和國科技部新藥基金評審委員
社會勞動保障部國家醫療保險藥物選審專家
國家法改委藥品價格評審委員會專家
國家重點新產品計畫評審專家
國家基本醫療保險諮詢專家
中華醫學會醫療事故鑑定委員會專家
北京市勞動鑑定委員會委員
北京市東城區醫療事故鑑定委員會

相關詞條

熱門詞條

聯絡我們